EMA Official Clarifies Benefits And Limitations Of Innovation Pathways

 
• By Eliza Slawther
  
EMA head of orphan medicines Kristina Larsson presenting virtually at the RAPS Euro Convergence 2025
EMA head of orphan medicines Kristina Larsson presenting virtually at the RAPS Euro Convergence 2025 (Pink Sheet)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from RAPS

More from Conferences